Background: Over the last few years, probiotics have been one of the most studied interventions in neonatal medicine. Objectives: The aim of this work was to analyse all studies (randomized controlled trials, RCTs, and observational studies) assessing the use of probiotics in very low birth weight (VLBW) preterm infants. Search Methods: A systematic literature search was conducted using PubMed, Embase, Cochrane Library, and Web of Science. The data from RCTs and observational studies were pooled and analysed separately. Selection Criteria: RCTs and observational studies that enrolled VLBW infants with enteral administration of probiotics were considered. Extracted study data included probiotic characteristics and at least 1 clinical outcome (necrotizing enterocolitis [NEC], late-onset sepsis or all-cause mortality). Data Collection and Analysis: Forty-four studies were eligible for our review: 30 RCTs and 14 observational studies. Severe NEC rates (stage II or more) and all-cause mortality were reduced among the probiotic groups in both the RCTs (RR 0.57, 95% CI 0.47-0.70, and RR 0.77, 95% CI 0.65-0.92, respectively) and the observational studies (RR 0.51, 95% CI 0.37-0.70, and RR 0.71, 95% CI 0.62-0.81, respectively). Furthermore, there was a 12% reduction in the risk of sepsis in RCTs and a 19% reduction in observational studies. The meta-analysis of observational studies showed a reduction in the risk of NEC in extremely low birth weight infants. However, this was not statistically significant. Conclusions: This meta-analysis of RCT and observational studies found that the use of probiotics was beneficial for the prevention of severe NEC, late-onset sepsis, and all-cause mortality in VLBW infants.

Keywords:
Probiotics, Preterm, Very low birth weight infants, Necrotizing enterocolitis, Mortality, Sepsis
1.
Berrington JE, Hearn RI, Bythell M, Wright C, Embleton ND: Deaths in preterm infants: changing pathology over 2 decades. J Pediatr 2012;160:49-53.
2.
Lee JS, Polin RA: Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 2003;8:449-459.
3.
Neu J: Necrotizing enterocolitis: the mystery goes on. Neonatology 2014;106:289-295.
4.
Dai D, Walker WA: Role of bacterial colonization in neonatal necro-tizing enterocolitis and its prevention. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998;39:357-365.
5.
Neu J: Neonatal necrotizing enterocolitis: an update. Acta Paediatr 2005;94:100-105.
6.
Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al: Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008;122:693-700.
7.
Mshvildadze M, Neu J, Mai V: Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship? Nutr Rev 2008;66:658-663.
8.
Cotton CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, et al: Net-work, prolonged duration of initial empirical antibiotic treatments associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66.
9.
AlFaleh K, Anabrees J: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014;4:CD005496.
10.
Deshpande G, Rao S, Patole S, Bulsara M: Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921-930.
11.
Olsen R, Greisen G, Schroder M, Brok J: Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology 2016;109:105-112.
12.
Cameron C, Fireman B, Hutton B, Clifford T, Coyle D, Wells G, et al: Network meta-analysis incorporating randomized controlled trials and nonrandomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. Syst Rev 2015;4:147.
13.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-e34.
14.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
15.
Higgins J, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. www.handbook.cochrane.org.
16.
Higgins JP, Altman DG, Gotzsche PC, Jüni P, Moher D, Oxman AD, et al: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
17.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al: GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-394.
18.
Wells GA, Shea B, O'Connel D, Peterson J, Welch V, Losos M, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2013. Ottawa, University of Ottawa, 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
19.
Al-Hosni M, Duenas M, Hawk M, Stewart LA, Borghese RA, Cahoon M, et al: Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012;32:253-259.
20.
Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al: Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-196.
21.
Braga TD, da Silva GAP, de Lira PI, de Carvalho LM: Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double blind, randomized, controlled trial. Am J Clin Nutr 2011;93:81-86.
22.
Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR, et al: Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387:649-660.
23.
Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol Neonate 2002;82:103-108.
24.
Demirel G, Erdeve O, Celik IH, Dilmen U: Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta Paediatr 2013;102:560-565.
25.
Dilli D, Aydin B, Fettah ND, Özyazıcı E, Beken S, Zenciroğlu A, et al: The ProPre-Save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr 2015;166:545-551.e1.
26.
Dutta S, Ray P, Narang A: Comparison of stool colonization in premature infants by three dose regimes of a probiotic combination: a randomized controlled trial. Am J Perinatol 2015;32:733-740.
27.
Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, et al: Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013;98:F5-F9.
28.
Fujii T, Ohtsuka Y, Lee T, Kudo T, Shoji H, Sato H, et al: Bifidobacterium breve enhances transforming growth factor A1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr 2006;43:83-88.
29.
Hays S, Jacquot A, Gauthier H, Kempf C, Beissel A, Pidoux O, et al: Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study. Clin Nutr 2016;35:802-811.
30.
Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al: Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013;132:1055-1062.
31.
Kanic Z, Micetic Turk D, Burja S, Kanic V, Dinevski D, et al: Influence of a combination of probiotics on bacterial infections in very low birthweight newborns. Wien Klin Wochenschr 2015;127(suppl 5):S210-S215.
32.
Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
33.
Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien R, et al: Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008;122:693-700.
34.
Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C, et al: Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006;42:1735-1742.
35.
Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H: Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates. JAMA 2009;302:1421-1428.
36.
Manzoni P, Meyerb M, Stolfi I, Rinaldi M, Cattani S, Pugni L, et al: Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 2014;90(suppl 1):S60-S65.
37.
Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F: Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010;98:156-163.
38.
Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, et al: Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birth weight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014;99:F110-F115.
39.
Patole S, Keil AD, Chang A, Nathan E, Doherty D, Simmer K, et al: Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates - a randomised double blind placebo controlled trial. PLoS One 2014;9:e89511.
40.
Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, et al: Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012;130:e1113-e1120.
41.
Rougé C, Piloquet H, Butel MJ, Berger B, Rochat F, Ferraris L, et al: Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009;89:1828-1835.
42.
Saengtawesin V, Tangpolkaiwalsak R, Kanjanapattankul W: Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. J Med Assoc Thai 2014;97:S20-S25.
43.
Samanta M, Sarkar M, Ghosh P, Ghosh JK, Sinha MK, Chatterjee S: Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009;55:128-131.
44.
Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U: Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011;65:434-439.
45.
Serce O, Benzer D, Gursoy T, Karatekin G, Ovali F: Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial. Early Hum Dev 2013;89:1033-1036.
46.
Tewari VV, Dubey SK, Gupta G: Bacillus clausii for prevention of late-onset sepsis in preterm infants: a randomized controlled trial. J Trop Pediatr 2015;61:377-385.
47.
Totsu S, Yamasaki C, Terahara M, Uchiyama A, Kusuda S, et al: Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr Int 2014;56:714-719.
48.
Bonsante F, Iacobelli S, Gouyon JB: Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol 2013;30:41-46.
49.
Dang S, Shook L, Garlitz K, Hanna M, Desai N: Nutritional outcomes with implementation of probiotics in preterm infants. J Perinatol 2015;35:447-450.
50.
Guthmann F, Arlettaz Mieth RP, Bucher HU, Bührer C: Short courses of dual-strain probiotics appear to be effective in reducing necrotising enterocolitis. Acta Paediatr 2015;255-259.
51.
Hoyos AB: Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3:197-202.
52.
Hunter C, Dimaguila MA, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ, et al: Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight <1,000 grams: a sequential analysis. BMC Pediatr 2012;12:142.
53.
Härtel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, et al: Prophylactic use of Lactobacillus acidophilus/Bifidobacte rium infantis probiotics and outcome in very low birth weight infants. J Pediatr 2014;165:285-289.e1.
54.
Janvier A, Malo J, Barrington KJ: Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr 2014;164:980-985.
55.
Lambæk ID, Fonnest G, Gormsen M, Brok J, Greisen G: Routine probiotic prophylaxis for necrotizing enterocolitis in very preterm infants: a planned historically controlled study. Dan Med J 2016;63:A5203.
56.
Li D, Rosito G, Slagle T: Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study. J Clin Pharm Ther 2013;38:445-449.
57.
Luoto R, Matomäki J, Isolauri E, Lehtonen L: Incidence of necrotizing enterocolitis in very low-birth-weight infants related to the use of Lactobacillus GG. Acta Paediatr 2010;99:1135-1138.
58.
Patole SK, Rao SC, Keil AD, Nathan EA, Doherty DA, Simmer KN: Benefits of Bifidobacterium breve M-16V supplementation in preterm neonates - a retrospective cohort Study. PLoS One 2016;11:e0150775.
59.
Repa A, Thanhaeuser M, Endress D, Weber M, Kreissl A, Binder C, et al: Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula. Pediatr Res 2015;77:381-388.
60.
Yamashiro Y, Nagata S: Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy. Benef Microbes 2010;1:357-365.
61.
Zampieri N, Pietrobelli A, Biban P, Soffiati M, Dall'Agnola A, Camoglio FS: Lactobacillus paracasei subsp. paracasei F19 in Bell's stage 2 of necrotizing enterocolitis. Minerva Pediatr 2013;65:353-360.
62.
Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, et al: Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003;74:89-96.
63.
Janvier A, Malo J, Barrington KJ: Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr 2014;164:980-985.
64.
Lau CS, Chamberlain RS: Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis. J Pediatr Surg 2015;50:1405-1412.
65.
Timmerman HM, Koning CJM, Mulder L, Rombouts FM, Beynen AC: Monostrain, multistrain and multispecies probiotics - a comparison of functionality and efficacy. Int J Food Microbiol 2004;96:219-233.
66.
Chapman CM, Gibson GR, Rowland I: Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 2011;50:1-17.
67.
Dani C, Coviello C, Corsini I, Arena F, Antonelli A, Rossolini GM: Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review. AJP Rep 2016;06:e25-e29.
68.
Kunz AN, Noel JM, Fairchok MP: Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004;38:457-458.
69.
De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR: Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005;24:278-280.
70.
Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK: Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115:178-181.
71.
Denkel LA, Schwab F, Garten L, Geffers C, Gastmeier P, Piening B: Protective effect of dual-strain probiotics in preterm infants: a multi-center time series analysis. PLoS One 2016;11:e0158136.
72.
Baucells BJ, Mercadal Hally M, Álvarez Sánchez AT, Figueras Aloy J: Probiotic associations in the prevention of necrotizing enterocolitis and the reduction of late-onset sepsis and neonatal mortality in preterm infants under 1500 g: a systematic review. An Pediatr (Barc) 2016;85:247-255.
73.
Olsen R, Greisen G, Schroder M, Brok J: Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology 2016;109:105-112.
74.
Aceti A, Gori D, Barone G, Callegari ML, Di Mauro A, Fantini MP, et al: Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis. Ital J Pediatr 2015;41:89.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.